Showing results (131-140 of 285) with videos related to
Sort By:
Pageof 29
Pediatric Blood & Cancer|June 18, 2016
Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In memory of Bob ArceciR Maarten Egeler, Satyendra Katewa, Pieter J M Leenen, et al.Surgical Neurology|April 25, 2000
The Dutch normal-pressure hydrocephalus study. How to select patients for shunting? An analysis of four diagnostic criteriaA J Boon, J T Tans, E J Delwel, et al.European Journal of Cancer (Oxford, England : 1990)|June 28, 2011
Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand?Jakob K Anninga, Hans Gelderblom, Marta Fiocco, et al.Anti-Cancer Drugs|September 27, 2006
Once-daily intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics and early clinical outcomesJuliette Zwaveling, Jan den Hartigh, Arjan C Lankester, et al.Plastic and Reconstructive Surgery|April 13, 2018
National Mortality Rates after Outpatient Cosmetic Surgery and Low Rates of Perioperative Deep Vein Thrombosis Screening and ProphylaxisAlexandra Bucknor, Sabine A Egeler, Austin D Chen, et al.Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|April 23, 2021
Hospital volume is associated with cost and outcomes variation in 2,942 pelvic reconstructionsDavid Chi, Austin D Chen, Alexandra Bucknor, et al.Genes, Chromosomes & Cancer|August 31, 2002
Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumorsMayi Y Arcellana-Panlilio, R Maarten Egeler, Eva Ujack, et al.European Journal of Neurology|November 29, 2013
Dutch normal pressure hydrocephalus study: baseline characteristics with emphasis on clinical findingsA J Boon, J T Tans, E J Delwel, et al.Trends in Cardiovascular Medicine|May 21, 2022
SGLT2 inhibitors in hypertension: Role beyond diabetes and heart failureRahul Gupta, Theresa Maitz, David Egeler, et al.Cytotherapy|November 22, 2015
Challenges in the harmonization of immune monitoring studies and trial design for cell-based therapies in the context of hematopoietic cell transplantation for pediatric cancer patientsStefan Nierkens, Arjan C Lankester, R Maarten Egeler, et al.Pageof 29